BMJ and LFA Join Forces to Publish First Open Access Journal Dedicated to Lupus
This article can be found in its entirety via this link. Please be aware that clicking the link will direct you away from our local website and you will be taken to the national LFA site.
International knowledge healthcare provider BMJ and the Lupus Foundation of America (LFA) have announced that they have joined forces to publish the first open access journal dedicated to the poorly understood and potentially life threatening disease, lupus.
Lupus Science & Medicine will offer timely global access to the latest scientific advances in lupus. The title will officially launch early next year.
Lupus Science & Medicine will be edited by Jill P Buyon, Division Director of Rheumatology, Professor of Medicine at New York University School of Medicine, and Ronald F van Vollenhoven, Professor and Chief, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID) The Karolinska Institute, Stockholm, Sweden.
Lupus research is currently published in a wide array of journals, particularly those in the specialties of rheumatology, immunology, dermatology and nephrology.
And the new online title will offer scientists and clinicians a unique focal point for new developments in the understanding and treatment of this complex and unpredictable autoimmune disease, the causes of which are still not clear.
Lupus represents a significant public health problem, affecting millions of people around the globe. In lupus the body’s immune system is out of balance, causing inflammation and tissue damage to any organ system in the body, including the skin, joints, heart and kidneys. Symptoms are varied and changeable, often mimicking other conditions, making lupus hard to diagnose and treat.
Read the rest of the article via this link. Please be aware that clicking the link will direct you away from our local website and you will be taken to the national LFA site.